More Evidence That We Should be Using Resuscitative Extracorporeal Membrane Oxygen Among the "Not Quite Dead Yet?": The Importance of Signs of Life Before Extracorporeal Cardiopulmonary Resuscitation Cannulation*

Joseph E Tonna,Joseph E. Tonna
DOI: https://doi.org/10.1097/ccm.0000000000006146
IF: 8.8
2024-03-16
Critical Care Medicine
Abstract:Extracorporeal membrane oxygen (ECMO) is well established as a resuscitative adjunct or treatment modality in severe respiratory failure ( 1 ), refractory cardiogenic shock ( 2 , 3 ), and during sudden cardiac arrest ( 4 , 5 )—where it can be applied during active chest compressions and is known as extracorporeal cardiopulmonary resuscitation (ECPR). Acknowledging some controversy over optimal use, we can observe that survival on ECMO is better among patients who are alive and have a pulse at the time of cannulation than among patients who are not and do not. Further, among patients who receive ECMO, be it for respiratory failure, cardiogenic shock, or cardiac arrest, observational data suggest earlier initiation ( 6–8 ) and initiation among lower severity of illness ( 9 ) is generally associated with better outcomes. What is relatively unknown is exactly how early.
critical care medicine
What problem does this paper attempt to address?